Home > Journals > Minerva Stomatologica > Past Issues > Minerva Stomatologica 1999 December;48(12) > Minerva Stomatologica 1999 December;48(12):615-20

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

ORIGINAL ARTICLES   

Minerva Stomatologica 1999 December;48(12):615-20

Copyright © 1999 EDIZIONI MINERVA MEDICA

language: Italian

Dental management of malignant hemopathology patients waiting for a bone marrow transplant

Bocca M., Coscia D., Bottalico L., De Stefano R.


PDF


Background. This study aims to identify the main oral lesions caused by the use of chemotherapeutic agents pre- and post-transplant in malignant hemopathologies and to highlight the importance of dental prevention during this treatment in order to reduce and, if possible, avoid the resulting local and systemic complications.
Methods. Twenty-five patients were controlled, monitored and prepared to undergo the necessary chemo- and radiotherapy, as well as bone marrow transplantation in the majority of cases under the best possible oral conditions.
Results. The most commonly detected secondary lesions were reactions to cyclophosphamide and/or methotrexate. In general, this mucositis appeared 5-7 days after treatment and continued for 1-2 weeks before regressing without residue. Another post-radiotherapeutic complication observed was xerostomy.
Conclusions. Lastly, it is important to underline that patients receiving correct dental infection preventive treatment showed fewer tertiary lesions than those who did not undergo the same procedure.

top of page